共 50 条
- [5] Tirzepatide vs Semaglutide in Obese Patients With MAFLD or MASH: A Comparative Analysis of Cardiovascular and Gastrointestinal Outcomes, and the Risk of Progression to Fibrosis or Hepatocellular Carcinoma AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1221 - S1222